FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100025800> ?p ?o ?g. }

• W2100025800 endingPage "1716" @default.
• W2100025800 startingPage "1707" @default.
• W2100025800 abstract "After breast-conserving surgery, radiotherapy reduces recurrence and breast cancer death, but it may do so more for some groups of women than for others. We describe the absolute magnitude of these reductions according to various prognostic and other patient characteristics, and relate the absolute reduction in 15-year risk of breast cancer death to the absolute reduction in 10-year recurrence risk.We undertook a meta-analysis of individual patient data for 10,801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (pN+) disease.Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35·0% to 19·3% (absolute reduction 15·7%, 95% CI 13·7-17·7, 2p<0·00001) and reduced the 15-year risk of breast cancer death from 25·2% to 21·4% (absolute reduction 3·8%, 1·6-6·0, 2p=0·00005). In women with pN0 disease (n=7287), radiotherapy reduced these risks from 31·0% to 15·6% (absolute recurrence reduction 15·4%, 13·2-17·6, 2p<0·00001) and from 20·5% to 17·2% (absolute mortality reduction 3·3%, 0·8-5·8, 2p=0·005), respectively. In these women with pN0 disease, the absolute recurrence reduction varied according to age, grade, oestrogen-receptor status, tamoxifen use, and extent of surgery, and these characteristics were used to predict large (≥20%), intermediate (10-19%), or lower (<10%) absolute reductions in the 10-year recurrence risk. Absolute reductions in 15-year risk of breast cancer death in these three prediction categories were 7·8% (95% CI 3·1-12·5), 1·1% (-2·0 to 4·2), and 0·1% (-7·5 to 7·7) respectively (trend in absolute mortality reduction 2p=0·03). In the few women with pN+ disease (n=1050), radiotherapy reduced the 10-year recurrence risk from 63·7% to 42·5% (absolute reduction 21·2%, 95% CI 14·5-27·9, 2p<0·00001) and the 15-year risk of breast cancer death from 51·3% to 42·8% (absolute reduction 8·5%, 1·8-15·2, 2p=0·01). Overall, about one breast cancer death was avoided by year 15 for every four recurrences avoided by year 10, and the mortality reduction did not differ significantly from this overall relationship in any of the three prediction categories for pN0 disease or for pN+ disease.After breast-conserving surgery, radiotherapy to the conserved breast halves the rate at which the disease recurs and reduces the breast cancer death rate by about a sixth. These proportional benefits vary little between different groups of women. By contrast, the absolute benefits from radiotherapy vary substantially according to the characteristics of the patient and they can be predicted at the time when treatment decisions need to be made.Cancer Research UK, British Heart Foundation, and UK Medical Research Council." @default.
• W2100025800 created "2016-06-24" @default.
• W2100025800 creator A5005887947 @default.
• W2100025800 creator A5015484254 @default.
• W2100025800 creator A5027517833 @default.
• W2100025800 creator A5027918729 @default.
• W2100025800 creator A5033653230 @default.
• W2100025800 creator A5035891540 @default.
• W2100025800 creator A5036540537 @default.
• W2100025800 creator A5039316545 @default.
• W2100025800 creator A5041941850 @default.
• W2100025800 creator A5050578761 @default.
• W2100025800 creator A5058873199 @default.
• W2100025800 creator A5071616473 @default.
• W2100025800 creator A5077992903 @default.
• W2100025800 creator A5085243640 @default.
• W2100025800 creator A5091277996 @default.
• W2100025800 date "2011-11-01" @default.
• W2100025800 modified "2023-10-14" @default.
• W2100025800 title "Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials" @default.
• W2100025800 cites W1961026612 @default.
• W2100025800 cites W1968075620 @default.
• W2100025800 cites W1971173102 @default.
• W2100025800 cites W1982853521 @default.
• W2100025800 cites W1996375113 @default.
• W2100025800 cites W2001584892 @default.
• W2100025800 cites W2024385229 @default.
• W2100025800 cites W2043468165 @default.
• W2100025800 cites W2046809995 @default.
• W2100025800 cites W2051008761 @default.
• W2100025800 cites W2100787775 @default.
• W2100025800 cites W2105365583 @default.
• W2100025800 cites W2108385373 @default.
• W2100025800 cites W2109964544 @default.
• W2100025800 cites W2119579521 @default.
• W2100025800 cites W2140893885 @default.
• W2100025800 cites W2145064229 @default.
• W2100025800 cites W2149455283 @default.
• W2100025800 cites W2152656144 @default.
• W2100025800 cites W2156003808 @default.
• W2100025800 cites W2158285353 @default.
• W2100025800 cites W2158615473 @default.
• W2100025800 cites W2169031890 @default.
• W2100025800 cites W2800860148 @default.
• W2100025800 cites W4233395937 @default.
• W2100025800 cites W4253957915 @default.
• W2100025800 cites W4293107555 @default.
• W2100025800 doi "https://doi.org/10.1016/s0140-6736(11)61629-2" @default.
• W2100025800 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3254252" @default.
• W2100025800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22019144" @default.
• W2100025800 hasPublicationYear "2011" @default.
• W2100025800 type Work @default.
• W2100025800 sameAs 2100025800 @default.
• W2100025800 citedByCount "2827" @default.
• W2100025800 countsByYear W21000258002012 @default.
• W2100025800 countsByYear W21000258002013 @default.
• W2100025800 countsByYear W21000258002014 @default.
• W2100025800 countsByYear W21000258002015 @default.
• W2100025800 countsByYear W21000258002016 @default.
• W2100025800 countsByYear W21000258002017 @default.
• W2100025800 countsByYear W21000258002018 @default.
• W2100025800 countsByYear W21000258002019 @default.
• W2100025800 countsByYear W21000258002020 @default.
• W2100025800 countsByYear W21000258002021 @default.
• W2100025800 countsByYear W21000258002022 @default.
• W2100025800 countsByYear W21000258002023 @default.
• W2100025800 crossrefType "journal-article" @default.
• W2100025800 hasAuthorship W2100025800A5005887947 @default.
• W2100025800 hasAuthorship W2100025800A5015484254 @default.
• W2100025800 hasAuthorship W2100025800A5027517833 @default.
• W2100025800 hasAuthorship W2100025800A5027918729 @default.
• W2100025800 hasAuthorship W2100025800A5033653230 @default.
• W2100025800 hasAuthorship W2100025800A5035891540 @default.
• W2100025800 hasAuthorship W2100025800A5036540537 @default.
• W2100025800 hasAuthorship W2100025800A5039316545 @default.
• W2100025800 hasAuthorship W2100025800A5041941850 @default.
• W2100025800 hasAuthorship W2100025800A5050578761 @default.
• W2100025800 hasAuthorship W2100025800A5058873199 @default.
• W2100025800 hasAuthorship W2100025800A5071616473 @default.
• W2100025800 hasAuthorship W2100025800A5077992903 @default.
• W2100025800 hasAuthorship W2100025800A5085243640 @default.
• W2100025800 hasAuthorship W2100025800A5091277996 @default.
• W2100025800 hasBestOaLocation W21000258002 @default.
• W2100025800 hasConcept C120195587 @default.
• W2100025800 hasConcept C121608353 @default.
• W2100025800 hasConcept C126322002 @default.
• W2100025800 hasConcept C141071460 @default.
• W2100025800 hasConcept C143998085 @default.
• W2100025800 hasConcept C2777176818 @default.
• W2100025800 hasConcept C2777757722 @default.
• W2100025800 hasConcept C2781467025 @default.
• W2100025800 hasConcept C44249647 @default.
• W2100025800 hasConcept C509974204 @default.
• W2100025800 hasConcept C530470458 @default.
• W2100025800 hasConcept C71924100 @default.
• W2100025800 hasConcept C82789193 @default.
• W2100025800 hasConceptScore W2100025800C120195587 @default.
• W2100025800 hasConceptScore W2100025800C121608353 @default.

• next